Location of ulcerations in diabetic patients may be explained by blood flow

April 09, 2003

April 9, 2003 (San Diego, CA) -- Sixty percent of hospital admissions of patients with diabetes are caused by complications of foot ulcers. More than 70 percent of these admissions require surgical intervention with 40 percent resulting in amputations. Of those with below knee amputations, 40 percent will require an amputation on the contralateral limb within three years.

It is estimated that at least half of the amputations are preventable through improved foot care programs. Unfortunately, significant portions of patients continue to develop plantar (sole of the foot) ulcers even with prescriptive footwear compliance. Consequently, efforts to understand the skin vasculature response to plantar pressures may provide insight into re-ulceration issues, since cutaneous perfusion is suspected to be influenced by arterial circulation but and the mechanical effects of repetitive pressure.


Type II diabetes is related to poor glycemic control and if uncontrolled, leads to microvascular and neuropathic complications that can result in foot ulceration and amputation. Paramount to diabetes control is glycemic control due to the strong relationship between hyperglycemia, microvascular complications and neuropathic symptoms. Much work is being done to evaluate treatments for improved glycemic control. Research is ongoing, but the strong causal relationship between poor glycemic control, poor microcirculation and peripheral neuropathy continues to cause insensate feet, poor skin circulation, high plantar pressures, ulceration, and eventually amputation.

Fifty percent of diabetic patients have some degree of peripheral sensory neuropathy, with nerve damage increasing in incidence with the duration of disease. The most common type of peripheral neuropathy affecting diabetic patients is symmetric polyneuropathy involving distal sensory and motor fibers. This causes sensory loss and motor abnormalities in the distal parts of the extremities, found most often with increased age, longer duration of diabetes, and male gender.

The costs are high. Peripheral neuropathy results in wasting of muscles controlling foot and ankle movement; muscle atrophy leads to foot deformities and an abnormal plantar pressure distribution; ankle joint deficits (limited range of motion) is associated with peripheral neuropathy and causes higher plantar pressures.

The location of increased plantar pressures correlates well with the presence of foot ulcers. The absence of muscle and nerve stimuli results in changes in walking behavior which positions the center of mass directly over the center of the stance foot; thus increasing body sway and increasing plantar pressure on the lateral aspect of the foot. Additionally, repetitively high dynamic plantar pressures contribute to callus formation, which is the most likely location of foot ulcers in neuropathic patients and is where highest maximum load and peak plantar pressures occur.

Preventing the occurrence of these ulcers is explored in "Pressure and Perfusion Imaging As Predictors of Diabetic Plantar Ulceration Risk," authored by Karen L. Perell PhD, RKT, of California State University at Fullerton's Division of Kinesiology and Health Promotion and the VA Greater Los Angeles Healthcare System; Oscar U. Scremin, MD, PhD, of the VA Greater Los Angeles Healthcare System; and Dante Chialvo, MD, of the VA Greater Los Angeles Healthcare System. The researchers will present their findings in detail during the American Physiological Society's (APS) annual meeting, part of the "Experimental Biology 2003" conference. More than 8,000 attendees will attend the conference being held in San Diego from April 11-14, 2003.


The research team used a laser technique in concert with plantar pressure distribution to map areas of greatest/lowest plantar pressure and skin perfusion distribution of the plantar surface of the foot. Five subjects (>50 years old) with diabetic peripheral neuropathy participated in the plantar pressure measurements and laser Doppler imaging. Subjects walked with specially designed insoles embedded in their shoes to record a two-dimensional graphic display of the plantar pressures during walking.

The peak plantar pressure value, which occurred during any point in the gait cycle, was obtained for specific points on the foot (first phalange, first metatarsal head, second metatarsal head, third and fourth metatarsal head, fifth metatarsal head, three consecutive areas on the medial and lateral borders of the foot, and heel). Each of the five trials required an average of three to five steps per foot.

A similar display of skin perfusion distribution over the plantar surface of the foot was recorded using a laser beam to scan the subjects they were lying prone. Scores measured highest skin perfusion to the lowest; plantar pressures scaled from highest to no pressure.


In the absence of compression (subjects lying prone on a bed) images showed maximal estimated skin perfusion at the heel and metatarsal heads, with intermediate levels on the lateral edge of the sole and minimal values in the rest of the plantar surface. The patterns of plantar pressures during walking generally reproduced the same distributions as the LDI images, with the striking exception at the first and second metatarsal heads where flow pattern is substantially less than that observed for pressures. The first and second metatarsal heads are locations of high incidence of ulceration.

In review of an initial 30 charts randomly selected from over 500 potential charts representing patients since in the VA Greater Los Angeles Healthcare System Podiatry clinics during calendar year 2001, 45 ulcerations were recorded via podiatric review.

Of the 45 ulcerations, 64 percent occurred across the metatarsal heads (13 percent under each of metatarsal heads one through four; four percent under metatarsal head number four; and 20 percent under metatarsal head number five). Only two percent (one ulcer) was observed on the plantar surface of the heel. The single largest percentage of ulcerations occurred on the plantar surface of the first toe.


A widely held belief is that the plantar surface of the heel rarely ulcerates in ambulatory diabetic peripheral neuropathy patients. The skin perfusion and plantar pressure relationships at each of these locations suggest an explanation for high incidence of ulceration across the metatarsal heads in diabetic patients. These areas (metatarsal heads) have high plantar pressures but lack high skin perfusion. On the other hand, the heel, which also experiences high plantar pressures, has high skin perfusion potentially serving as a protective mechanism against ulceration. Further work to evaluate this relationship in non-diabetic older adults and diabetic non-peripheral neuropathy patients is necessary to understand the phenomena more clearly.

This work provides the basis for the use of the reactive hyperemia response as a predictor of future ulceration. Ultimately, this research will lead to treatments, which propose to alter the repetitive pressures experienced by the plantar surface of the foot to improve skin vascular compensatory mechanisms.
The American Physiological Society (APS) is one of the world's most prestigious organizations for physiological scientists. These researchers specialize in understanding the processes and functions underlying human health and disease. Founded in 1887 the Bethesda, MD-based Society has more than 10,000 members and publishes 3,800 articles in its 14 peer-reviewed journals each year.

Contact: Donna Krupa at 703-527-7357 (vm) Or 703-967-2751 (cell) or djkrupa1@aol.com
Through April 10th, 2003


APS Newsroom: April 11-15, 2003
San Diego Convention Center
Hall A (Flex Unit)
Telephone: 619-525-6340 or 6341

American Physiological Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.